Other News To Note
Tuesday, August 16, 2011
Lpath Inc., of San Diego, said the National Institutes of Health's Type I Diabetes Preclinical Testing Program will provide financial support for the further study of Lpathomab's efficacy in animal models of the disease, particularly diabetic neuropathy. The award will provide NIH contract resources to conduct in vivo studies of the monoclonal antibody in rats.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.